Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.48 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.48 |
| ▸ | PTPRC | P08575 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18116124 | 0.99 | MAOB (0.54) | MAOBMAOAALOX5PLA2G2APLA2G4A | |
| SCHEMBL13991400 | 0.99 | MAOB (0.54) | MAOBMAOAALOX5PLA2G2APLA2G4A | |
| SCHEMBL15195291 | 0.96 | MAOB (0.51) | MAOBMAOAALOX5PLA2G2APLA2G4A | |
| SCHEMBL13991431 | 0.95 | ALOX5 (0.55) | MAOBMAOAALOX5PLA2G2APLA2G4A | |
| SCHEMBL18116123 | 0.94 | MAOB (0.52) | MAOBMAOAALOX5PLA2G2APLA2G4A | |
| SCHEMBL13991399 | 0.94 | MAOB (0.51) | MAOBMAOAALOX5PLA2G2APLA2G4A | |
| SCHEMBL15195309 | 0.92 | MAOB (0.63) | MAOBMAOAALOX5PLA2G2APLA2G4A | |
| SCHEMBL18116121 | 0.91 | MAOB (0.51) | MAOBMAOAALOX5PLA2G2APLA2G4A | |
| SCHEMBL15195294 | 0.91 | ALOX5 (0.51) | MAOBMAOAALOX5PLA2G2APLA2G4A | |
| SCHEMBL15195308 | 0.91 | MAOB (0.58) | MAOBMAOAALOX5PLA2G2APLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9461251-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-9461251-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| EP-2163550-B1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IDEMITSU KOSAN CO (JP) | 2015-09-09 | — | — | EP | disclosed |
| US-8512875-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| US-8512875-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| EP-2163550-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-17 | — | — | EP | disclosed |
| US-20080315754-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080315754-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080315754-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | APRT, ETFA, MLLT3 | MAOB 349/4885MAOA 97/4885ALOX5 520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.